A model-based selection approach to identify suitable indications for proton therapy

IBCD 2016: Patient access and regulatory challenges

Screening Patients for Efficient Clinical Trial Access (SPECTA)

How to avoid false positives in lung cancer

Recent advances and emerging therapies in lung cancer

Developments in gastrointestinal tumour treatment

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?

Advances in early detection

Changing landscape of multiple myeloma care: Expert discussion

Monitoring the cancer genome in plasma using circulating tumour DNA

Cancer organoids

Prostate cancer screening: A north/south comparison in Ireland